NCT00497042

Brief Summary

The study's primary goal is to assess the safety of the SAF (Self Adjusting File) device for root canal treatments. The study's secondary goal is to evaluate the effectiveness of the SAF device for root canal treatments

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 6, 2007

Completed
Last Updated

July 11, 2007

Status Verified

July 1, 2007

First QC Date

July 4, 2007

Last Update Submit

July 10, 2007

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment related operative and postoperative major complications.

    One year.

Secondary Outcomes (1)

  • Healing of pariapical leasions as a result of the endodontic treatment.

    One year.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects is 18 years or older
  • Subject has one or more teeth that have to go through a root canal treatment
  • Roots are fully formed and with a mature apex
  • At least one of the roots to be treated has periapical radiolucency with a diameter of 2-6mm and a PAI score of 4 or 5
  • Subject had signed the informed consent form

You may not qualify if:

  • Previous root canal filling
  • Roots with abnormal root canal anatomy
  • Roots for which a good quality periapical radiographic image cannot be produced
  • Un-restorable teeth
  • Significant periodontal pockets
  • Patients who are pregnant or breast-feeding
  • Uncontrolled systemic hypertension
  • Severe uncontrolled Diabetes Mellitus
  • Current steroid therapy in excess of prednisone 5 mg/day
  • HIV positive patients
  • Hepatitis
  • Chronic renal failure
  • Hematological disease (malignancy, severe anemia)
  • Osteoporosis, receiving biphosphonates
  • Post head and neck irradiation treatment
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv Souraski Medical Center

Tel Aviv, Israel

Location

MeSH Terms

Conditions

Tooth, Nonvital

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Study Officials

  • Amnon Singer, DMD

    Redent Nova Ltd.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amnon Singer, DMD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 4, 2007

First Posted

July 6, 2007

Last Updated

July 11, 2007

Record last verified: 2007-07

Locations